Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Part of an E-Mail from MP Today

<< Previous

Bullboard Posts

Next >>

Comment by menoalittleon Oct 12, 2024 1:11pm

231 Views

Post# 36264007

RE:RE:RE:Part of an E-Mail from MP Today

Negotiating any JV from a position of attained BTD, the significantly increasing potential of Rutherrin, and a relatively low total outstanding share count is not only going to outweigh any position of weakness that TLT might currently be perceived being in, but it is going to MORE than compensate us extremely well for the temporary discomfort of having had our share priced capped for as long as it's been...

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments